Associations of long-term and early adult atherosclerosis risk factors with aortic and mitral valve calcium
- PMID: 20510217
- PMCID: PMC3042249
- DOI: 10.1016/j.jacc.2010.03.019
Associations of long-term and early adult atherosclerosis risk factors with aortic and mitral valve calcium
Abstract
Objectives: To determine the association of long-term exposure to atherosclerosis risk factors with valvular calcification.
Background: Traditional atherosclerosis risk factors have been associated with aortic and mitral valve calcium in cross-sectional studies, but long-term prospective data are lacking.
Methods: This was a prospective, community-based cohort study with 27-year follow-up (median follow-up 26.9 years; range 23.1 to 29.6 years). Participants from the Framingham Offspring Study (n = 1,323, enrolled between 1971 and 1975, mean age at enrollment 34 +/- 9 years; 52% women) underwent cardiac multidetector computed tomography assessment between 2002 and 2005. Associations between the long-term average of each cardiovascular risk factor and valve calcium were estimated using logistic regression.
Results: Aortic valve calcium was present in 39% of participants and mitral valve calcium in 20%. In multivariable models, the odds ratio for aortic valve calcium associated with every SD increment in long-term mean total cholesterol was 1.74 (p < 0.0001); with every SD increment in high-density lipoprotein cholesterol, it was 0.77 (p = 0.002); and with every 9 cigarettes smoked per day, it was 1.23 (p = 0.002). Associations of similar magnitude were seen for mitral valve calcium. The mean of 3 serum C-reactive protein measurements was associated with mitral valve calcium (odds ratio: 1.29 per SD increment in C-reactive protein levels; p = 0.002). A higher Framingham risk score in early adulthood (40 years age or younger) was associated with increased prevalence and severity of aortic valve calcium measured 3 decades later.
Conclusions: Exposure to multiple atherosclerotic risk factors starting in early to mid-adulthood is associated with aortic and mitral valve calcium. Studies evaluating early risk factor modification to reduce the burden of valve disease are warranted.
Figures





Similar articles
-
Cardiovascular Event Prediction and Risk Reclassification by Coronary, Aortic, and Valvular Calcification in the Framingham Heart Study.J Am Heart Assoc. 2016 Feb 22;5(2):e003144. doi: 10.1161/JAHA.115.003144. J Am Heart Assoc. 2016. PMID: 26903006 Free PMC article.
-
Biomarkers of mineral metabolism and progression of aortic valve and mitral annular calcification: The Multi-Ethnic Study of Atherosclerosis.Atherosclerosis. 2019 Jun;285:79-86. doi: 10.1016/j.atherosclerosis.2019.04.215. Epub 2019 Apr 13. Atherosclerosis. 2019. PMID: 31048102 Free PMC article.
-
Lipoprotein(a) and Subclinical Vascular and Valvular Calcification on Cardiac Computed Tomography: The Atherosclerosis Risk in Communities Study.J Am Heart Assoc. 2022 Jun 7;11(11):e024870. doi: 10.1161/JAHA.121.024870. Epub 2022 Jun 3. J Am Heart Assoc. 2022. PMID: 35656990 Free PMC article.
-
Aortic sclerosis and mitral annulus calcification: a window to vascular atherosclerosis?Expert Rev Cardiovasc Ther. 2013 Jul;11(7):863-77. doi: 10.1586/14779072.2013.811978. Expert Rev Cardiovasc Ther. 2013. PMID: 23895030 Review.
-
Mitral Annulus Calcification.J Am Coll Cardiol. 2015 Oct 27;66(17):1934-41. doi: 10.1016/j.jacc.2015.08.872. J Am Coll Cardiol. 2015. PMID: 26493666 Review.
Cited by
-
Cellular Senescence, Aging and Non-Aging Processes in Calcified Aortic Valve Stenosis: From Bench-Side to Bedside.Cells. 2022 Oct 27;11(21):3389. doi: 10.3390/cells11213389. Cells. 2022. PMID: 36359785 Free PMC article. Review.
-
Association of Triglyceride-Related Genetic Variants With Mitral Annular Calcification.J Am Coll Cardiol. 2017 Jun 20;69(24):2941-2948. doi: 10.1016/j.jacc.2017.04.051. J Am Coll Cardiol. 2017. PMID: 28619195 Free PMC article. Clinical Trial.
-
Biomarkers in Cardiology - Part 2: In Coronary Heart Disease, Valve Disease and Special Situations.Arq Bras Cardiol. 2015 May;104(5):337-46. doi: 10.5935/abc.20150061. Epub 2015 May 1. Arq Bras Cardiol. 2015. PMID: 26083777 Free PMC article. Review.
-
Lipoprotein(a), a Lethal Player in Calcific Aortic Valve Disease.Front Cell Dev Biol. 2022 Jan 27;10:812368. doi: 10.3389/fcell.2022.812368. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35155427 Free PMC article. Review.
-
Prognostic value of mitral annular calcification in coronary atherosclerotic disease assessed by coronary computed tomographic angiography.J Res Med Sci. 2024 Jan 30;29:3. doi: 10.4103/jrms.jrms_53_23. eCollection 2024. J Res Med Sci. 2024. PMID: 38524747 Free PMC article.
References
-
- Cosmi JE, Kort S, Tunick PA, et al. The Risk of the Development of Aortic Stenosis in Patients With "Benign" Aortic Valve Thickening. Arch Intern Med. 2002;162:2345–2347. - PubMed
-
- Chan KL. Is aortic stenosis a preventable disease? J Am Coll Cardiol. 2003;42:593–599. - PubMed
-
- O'Brien KD, Reichenbach DD, Marcovina SM, Kuusisto J, Alpers CE, Otto CM. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. Arterioscler Thromb Vasc Biol. 1996;16:523–532. - PubMed
-
- Olsson M, Dalsgaard CJ, Haegerstrand A, Rosenqvist M, Ryden L, Nilsson J. Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol. 1994;23:1162–1170. - PubMed
-
- Olsson M, Thyberg J, Nilsson J. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol. 1999;19:1218–1222. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials